Allogene Therapeutics (ALLO) stock Forecast for 2022, 2023, 2024, 2025.

Allogene Therapeutics (ALLO) stock Forecast for 2022 – 2026

Last update: January 27, 2023 (12:50)

Sector: Healthcare

The share price of Allogene Therapeutics, Inc. (ALLO) now

What analysts predict: $22.53
52-week High/Low: $17.49 / $5.41

50/200 Day Moving Average: $7.95 / $10.33

This figure corresponds to the Average Price over the previous 50/200 days. For Allogene Therapeutics stocks, the 50-day moving average is the resistance level today.

For Allogene Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Allogene Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Allogene Therapeutics stock price in 2023, 2024, 2025, 2026, 2027. How much will one Allogene Therapeutics share be worth in 2023 - 2027?

When should I take profit in Allogene Therapeutics stock? When should I record a loss on Allogene Therapeutics stock? What are analysts' forecasts for Allogene Therapeutics stock? What is the future of Allogene Therapeutics stock? We forecast Allogene Therapeutics stock performance using neural networks based on historical data on Allogene Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Allogene Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Allogene Therapeutics shares. This happens once a day.




Historical and forecast chart of Allogene Therapeutics stock

The chart below shows the historical price of Allogene Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Allogene Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Allogene Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Jan 29 8.30 8.08 8.66 7.19
Jan 30 8.36 8.09 8.55 5.72
Jan 31 8.60 8.14 8.99 10.35
Feb 01 8.70 8.33 8.95 7.53
Feb 02 9.02 8.77 9.28 5.76
Feb 03 8.75 8.54 9.04 5.88
Feb 04 8.64 8.29 8.95 7.87
Feb 05 8.53 8.39 8.81 5.06
Feb 06 8.24 7.78 8.66 11.35
Feb 07 7.84 7.71 8.13 5.55
Feb 08 8.00 7.58 8.25 8.87
Feb 09 7.73 7.39 7.96 7.69
Feb 10 7.60 7.40 7.93 7.20
Feb 11 7.35 7.12 7.66 7.67
Feb 12 7.49 7.34 7.84 6.94
Feb 13 7.72 7.42 7.90 6.48
Feb 14 8.20 7.91 8.59 8.56
Feb 15 8.65 8.40 8.77 4.39
Feb 16 8.93 8.65 9.14 5.64
Feb 17 9.16 8.91 9.46 6.27
Feb 18 9.01 8.57 9.23 7.65
Feb 19 8.84 8.49 9.09 6.99
Feb 20 9.10 8.72 9.40 7.82
Feb 21 9.36 9.12 9.67 6.04
Feb 22 9.03 8.91 9.32 4.61
Feb 23 8.98 8.69 9.26 6.66
Feb 24 8.86 8.54 9.15 7.12
Feb 25 9.11 8.78 9.43 7.48
Feb 26 8.91 8.48 9.04 6.54
Feb 27 8.66 8.37 9.03 7.90

Allogene Therapeutics Daily Price Targets


Allogene Therapeutics Stock Forecast 01-29-2023.

Forecast target price for 01-29-2023: $8.30.
Positive dynamics for Allogene Therapeutics shares will prevail with possible volatility of 6.704%.
Pessimistic target level: 8.08
Optimistic target level: 8.66

Allogene Therapeutics Stock Forecast 01-30-2023.

Forecast target price for 01-30-2023: $8.36.
Positive dynamics for Allogene Therapeutics shares will prevail with possible volatility of 5.409%.
Pessimistic target level: 8.09
Optimistic target level: 8.55

Allogene Therapeutics Stock Forecast 01-31-2023.

Forecast target price for 01-31-2023: $8.60.
Positive dynamics for Allogene Therapeutics shares will prevail with possible volatility of 9.380%.
Pessimistic target level: 8.14
Optimistic target level: 8.99

Allogene Therapeutics Stock Forecast 02-01-2023.

Forecast target price for 02-01-2023: $8.70.
Positive dynamics for Allogene Therapeutics shares will prevail with possible volatility of 7.004%.
Pessimistic target level: 8.33
Optimistic target level: 8.95

Allogene Therapeutics Stock Forecast 02-02-2023.

Forecast target price for 02-02-2023: $9.02.
Positive dynamics for Allogene Therapeutics shares will prevail with possible volatility of 5.444%.
Pessimistic target level: 8.77
Optimistic target level: 9.28

Allogene Therapeutics Stock Forecast 02-03-2023.

Forecast target price for 02-03-2023: $8.75.
Negative dynamics for Allogene Therapeutics shares will prevail with possible volatility of 5.553%.
Pessimistic target level: 8.54
Optimistic target level: 9.04

ALLO (ALLO) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Feb. 6.74 6.43 7.25 11.26
Mar. 7.25 7.06 7.78 9.22
Apr. 7.36 6.90 7.86 12.17
May. 6.80 6.40 6.94 7.75
Jun. 6.67 6.29 6.90 8.89
Jul. 6.67 6.21 6.92 10.32
Aug. 6.50 5.99 6.66 9.96
Sep. 6.49 5.99 6.84 12.35
Oct. 6.78 6.59 7.00 5.91
Nov. 6.47 6.17 6.88 10.24
Dec. 6.01 5.68 6.43 11.67

Allogene Therapeutics forecast for this year


Allogene Therapeutics Stock Prediction for Feb 2023

An downtrend is forecast for this month with an optimal target price of $6.73995. Pessimistic: $6.43. Optimistic: $7.25


Allogene Therapeutics Stock Prediction for Mar 2023

An uptrend is forecast for this month with an optimal target price of $7.24545. Pessimistic: $7.06. Optimistic: $7.78


Allogene Therapeutics Stock Prediction for Apr 2023

An uptrend is forecast for this month with an optimal target price of $7.36137. Pessimistic: $6.90. Optimistic: $7.86


Allogene Therapeutics Stock Prediction for May 2023

An downtrend is forecast for this month with an optimal target price of $6.80191. Pessimistic: $6.40. Optimistic: $6.94


Allogene Therapeutics Stock Prediction for Jun 2023

An downtrend is forecast for this month with an optimal target price of $6.66587. Pessimistic: $6.29. Optimistic: $6.90


Allogene Therapeutics Stock Prediction for Jul 2023

An uptrend is forecast for this month with an optimal target price of $6.67254. Pessimistic: $6.21. Optimistic: $6.92


Allogene Therapeutics Stock Prediction for Aug 2023

An downtrend is forecast for this month with an optimal target price of $6.49905. Pessimistic: $5.99. Optimistic: $6.66


Allogene Therapeutics Stock Prediction for Sep 2023

An downtrend is forecast for this month with an optimal target price of $6.49255. Pessimistic: $5.99. Optimistic: $6.84


Allogene Therapeutics Stock Prediction for Oct 2023

An uptrend is forecast for this month with an optimal target price of $6.78472. Pessimistic: $6.59. Optimistic: $7.00


Allogene Therapeutics Stock Prediction for Nov 2023

An downtrend is forecast for this month with an optimal target price of $6.46583. Pessimistic: $6.17. Optimistic: $6.88


Allogene Therapeutics Stock Prediction for Dec 2023

An downtrend is forecast for this month with an optimal target price of $6.00676. Pessimistic: $5.68. Optimistic: $6.43



Allogene Therapeutics (ALLO) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 5.45 5.28 5.69 7.18
Feb 5.19 4.93 5.40 8.65
Mar 5.19 4.98 5.59 10.95
Apr 5.59 5.19 6.03 13.89
May 5.69 5.44 5.92 8.17
Jun 5.75 5.51 5.98 7.98
Jul 5.98 5.76 6.43 10.42
Aug 6.19 6.05 6.31 4.12
Sep 5.60 5.16 6.03 14.48
Oct 5.84 5.54 6.23 10.97
Nov 5.72 5.55 6.12 9.35
Dec 5.77 5.41 5.94 8.94

Allogene Therapeutics (ALLO) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 6.13 5.82 6.45 9.80
Feb 6.58 6.31 7.00 9.86
Mar 6.28 6.11 6.76 9.57
Apr 6.88 6.55 7.11 7.93
May 7.07 6.50 7.52 13.53
Jun 6.38 6.18 6.84 9.61
Jul 6.35 5.90 6.56 10.07
Aug 6.27 6.07 6.53 7.01
Sep 6.41 6.15 6.80 9.61
Oct 6.55 6.11 6.90 11.40
Nov 6.48 6.09 6.95 12.49
Dec 6.22 5.85 6.60 11.39

Allogene Therapeutics (ALLO) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 6.08 5.85 6.28 6.87
Feb 6.65 6.18 7.10 12.92
Mar 6.76 6.49 6.92 6.26
Apr 6.72 6.33 6.92 8.54
May 6.70 6.45 7.02 8.02
Jun 6.07 5.93 6.36 6.87
Jul 6.14 5.67 6.41 11.59
Aug 6.27 5.94 6.61 10.15
Sep 6.63 6.41 7.02 8.68
Oct 7.24 7.08 7.73 8.43
Nov 7.71 7.47 7.88 5.19
Dec 8.08 7.55 8.37 9.75

Allogene Therapeutics (ALLO) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 8.03 7.73 8.55 9.58
Feb 7.95 7.49 8.11 7.55
Mar 8.56 7.93 9.15 13.28
Apr 8.28 7.78 8.86 12.16
May 8.44 7.78 9.12 14.63
Jun 8.77 8.40 9.45 11.05
Jul 7.96 7.77 8.51 8.69
Aug 7.78 7.54 8.28 8.93
Sep 7.39 7.15 7.78 8.17
Oct 7.12 6.69 7.55 11.40
Nov 6.81 6.47 7.14 9.34
Dec 7.28 6.94 7.62 8.98

Allogene Therapeutics information and performance

Allogene Therapeutics, Inc. operates as a biotechnology company. The Company develops allogeneic chimeric antigen receptor T-cell therapy for the treatment of blood cancers and solid tumors. Allogene Therapeutics serves patients in the State of California.

Official site of the company

Allogene Therapeutics Address

210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, US

Market Capitalization: 944 576 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -297 499 008 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.2

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 2674.75

Enterprise Value (EV) /Revenue

EV To EBITDA: -2.221

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 144210000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.